Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2401853.pdf
Reference30 articles.
1. Yates JW, Glidwell O, Wiernik PH, Cooper MR, Steinberg D, Desik H, Levy R, Hoogland C, Henry P, Gottleib A, Cornell C, Berenberg J, Hutchinson JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Hendersen E, Leone L, Holland JF . Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study Blood 1982 60: 454–462
2. Tallman MS, Appelbaum FR, Amos D, Goldberg RS, Livingston RB, Mortimer J, Weiden PL, Thomas ED . Evaluation of intensive consolidation therapy or adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with asparaginase and amsacrine with etoposide J Clin Oncol 1987 55: 918–926
3. Wiernik PH, Banks PLC, Case DC, Arlin ZA, Periman PO, Todd MB, Ritch PS, Enck RE, Wortberg AB . Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia Blood 1992 79: 313–319
4. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E . Intensive postremission chemotherapy in adults with acute myeloid leukemia New Engl J Med 1994 331: 896–903
5. Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth Pa, Stadtmauer EA, Wiernik PH . A randomized placebo-controlled phase III study of granulocyte-macrophagecolony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490) Blood 1995 86: 457–462
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer: slaying the nine-headed Hydra;Annals of Oncology;2023-01
2. Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques;PLOS ONE;2021-07-21
3. CAR T-Cell Therapy with NKG2D Chimeric Antigen Receptor in Relapsed/ Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome;Clinical oncohematology;2021
4. Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia;American Journal of Hematology;2018-11-25
5. Diagnosis and Treatment of Adult Acute Myeloid Leukemia Other than Acute Promyelocytic Leukemia;Neoplastic Diseases of the Blood;2017-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3